Your browser doesn't support javascript.
loading
Development and validation of a robust immune-related risk signature for hepatocellular carcinoma.
Liu, Zaoqu; Jiao, Dechao; Liu, Long; Zhou, Xueliang; Yao, Yuan; Li, Zhaonan; Li, Jing; Chen, Jianjian; Lei, Qinyu; Han, Xinwei.
Affiliation
  • Liu Z; Department of Interventional Radiology.
  • Jiao D; Department of Interventional Radiology.
  • Liu L; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China.
  • Zhou X; Department of Interventional Radiology.
  • Yao Y; Department of Interventional Radiology.
  • Li Z; Department of Interventional Radiology.
  • Li J; Department of Interventional Radiology.
  • Chen J; Department of Interventional Radiology.
  • Lei Q; Department of Interventional Radiology.
  • Han X; Department of Interventional Radiology.
Medicine (Baltimore) ; 100(10): e24683, 2021 Mar 12.
Article in En | MEDLINE | ID: mdl-33725827
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Carcinoma, Hepatocellular / Immune Checkpoint Proteins / Liver Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Medicine (Baltimore) Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Carcinoma, Hepatocellular / Immune Checkpoint Proteins / Liver Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Medicine (Baltimore) Year: 2021 Document type: Article